All Articles

With a $22M Series A and a factory-focused plan, Foundation Alloy is moving to scale a melt-free metallurgy process that could redefine global manufacturing.

Aya Gold & Silver's inclusion in the GDX Gold Miners ETF marks a major milestone, validating its explosive growth and strategic execution at its Moroccan mines.

As the AI boom pushes data center energy demand to its limits, Cipher Digital's hire of ERCOT veteran Bill Blevins is a masterstroke in a new high-stakes game.

Manchester United partners with Elevate, using AI to redefine the Old Trafford experience. But can data-driven luxury coexist with the soul of the game?

Insurtech firm PolicyMe has launched a unified platform promising to match any Canadian to the right life insurance in one session. Is this the innovation that finally cracks the industry's complexity, or a new tech facing a tough regulatory road?

Mars hits a 100% renewable US energy milestone, but is it a true blueprint for corporate climate action? A deep dive into the story behind the numbers.

With $10M in funding, Magnitude launches an autonomous AI workforce to combat machine-speed threats, forcing a reckoning in third-party risk management.

With a third consecutive GigaOm Leader nod, Scale Computing isn't just innovating; it's defining the future of distributed enterprise IT. What's their secret?

Beyond the awards, a Texas healthcare giant’s investment in paid leave and remote work reveals a powerful strategy for talent retention and market leadership.

The company behind the first FDA-cleared birth control app is expanding into a holistic wellness platform, a strategic move that could redefine the FemTech market.

Verge Labs' new AI model promises to predict brain activity from a blood draw, potentially upending the costly and failure-prone world of neurology R&D.

A major deal between Aeva and Bendix brings advanced 4D LiDAR to commercial trucking, promising enhanced safety and signaling a major shift in the ADAS industry.

A single soldier controlling a swarm of drones in a contested battle. Palladyne AI's recent test with the U.S. Army signals a major leap in autonomy.

German firm NVision wins a top award for POLARIS, a quantum-enhanced MRI platform that shows if cancer therapy is working weeks or months sooner.

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.

Bigleaf and CSG are rewriting the rules of business internet, combining 5G and Starlink not for backup, but for a unified, high-performance connection.

As Latus Bio advances its Huntington's therapy to clinic, new CBO Bethany Mancilla brings a history of high-value deals to fuel the company's growth.

A new survey reveals an overwhelming public demand to treat epinephrine like defibrillators. This isn't just about allergies; it's a systemic shift in our definition of public safety.

A rebrand, a football partnership, and a $25,000 cheque. Western Financial Group’s recent event is a case study in how to turn corporate strategy into local good.